Publications by authors named "Peter Koson"

Claim this Profile
A
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease.
Petr Novak, Branislav Kovacech, Stanislav Katina, Reinhold Schmidt, Philip Scheltens, Peter Koson

Nat Aging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNAs as biofluid markers for diagnostics of Alzheimer's disease: recent status and perspectives.
Nina Kosikova, Martin Cente, Viera Cigankova, Peter Koson, Peter Filipcik

Gen Physiol Biophys· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases.
Babette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, Fay Betsou, Kaj Blennow, Peter Koson

Front Neurol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First transgenic rat model developing progressive cortical neurofibrillary tangles.
Peter Filipcik, Norbert Zilka, Ondrej Bugos, Juraj Kucerak, Peter Koson

Neurobiol Aging· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Simone Mader, Viktoria Gredler, Kathrin Schanda, Kevin Rostasy, Irena Dujmovic, Peter Koson

J Neuroinflammation· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Peter Koson, Norbert Zilka, Andrej Kovac, Branislav Kovacech, Miroslava Korenova

Eur J Neurosci· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats.
Miroslava Hrnkova, Norbert Zilka, Zuzana Minichova, Peter Koson, Michal Novak

Brain Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
Norbert Zilka, Peter Filipcik, Peter Koson, Lubica Fialova, Rostislav Skrabana

FEBS Lett· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis